GenPharm Services

GENPHARM provides rapid market access for rare disease and specialty pharmaceutical companies seeking to enter the Middle East and North Africa (MENA) region. It is a regional leader in the field of rare diseases and the only regional company with expertise in gene therapy. Established in 2012, GENPHARM is headquartered in Dubai Science Park (DSP), UAE, with offices in Boston’s biotech hub and Ireland. Operating through evidence-based medicine and the highest ethical standards, Genpharm offers its partners fast and sustainable market access solutions into the MENA region. Genpharm has a highly qualified and experienced team of MSLs and KAMs and provides regulatory, medical, pharmacovigilance, and logistical support. With an understanding of local business culture and a trusted network of partners, GENPHARM’s expertise enables it to create market opportunities for innovative healthcare products and services. Current partners include Avexis, Novartis, Sarepta, PTC, Ultragenyx, Biohaven, Genzyme, GSK, Sintetica, Admedus, ABiotics, and more.